CAR T-Cell Therapy on the Horizon for R/R Multiple Myeloma CAR T-Cell Therapy on the Horizon for R/R Multiple Myeloma

Two products have shown impressive responses, and CAR T-cell therapy may soon find its way into the treatment landscape of relapsed or refractory multiple myeloma.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news